Benzodiazepines and Related Sedatives.
Peng L, Morford KL, Levander XA.
Med Clin North Am. 2022 Jan;106(1):113-129. doi: 10.1016/j.mcna.2021.08.012.
Nationwide trends in diagnosed sedative, hypnotic or anxiolytic use disorders in adolescents and young adults enrolled in Medicaid: 2001-2019.
Bushnell G, Lloyd K, Olfson M, Gerhard T, Keyes K, Cerdá M, Hasin D.
Addiction. 2025 May;120(5):951-961. doi: 10.1111/add.16749. Epub 2025 Jan 22.
Prevalence of concomitant use of alcohol and sedative-hypnotic drugs in middle and older aged persons: a systematic review.
Ilomäki J, Paljärvi T, Korhonen MJ, Enlund H, Alderman CP, Kauhanen J, Bell JS.
Ann Pharmacother. 2013 Feb;47(2):257-68. doi: 10.1345/aph.1R449. Epub 2013 Jan 29.
Sedative-hypnotics: pharmacology and use.
Miller NS, Gold MS.
J Fam Pract. 1989 Dec;29(6):665-70.
Sleeping-pill insomnia.
Williams RL.
J Clin Psychiatry. 1980 May;41(5):153-4.
DARK Classics in Chemical Neuroscience: Methaqualone.
Inger JA, Mihan ER, Kolli JU, Lindsley CW, Bender AM.
ACS Chem Neurosci. 2023 Feb 1;14(3):340-350. doi: 10.1021/acschemneuro.2c00697. Epub 2023 Jan 18.
Newly Emerging Drugs of Abuse.
Tamama K, Lynch MJ.
Handb Exp Pharmacol. 2020;258:463-502. doi: 10.1007/164_2019_260.
Drugs of Abuse-Opioids, Sedatives, Hypnotics.
Azevedo K, Johnson M, Wassermann M, Evans-Wall J.
Crit Care Clin. 2021 Jul;37(3):501-516. doi: 10.1016/j.ccc.2021.03.003.
History and current status of sedative-hypnotic drug use and abuse.
Allgulander C.
Acta Psychiatr Scand. 1986 May;73(5):465-78. doi: 10.1111/j.1600-0447.1986.tb02713.x.
[Sleep].
Tarentini Trojani F.
Clin Ter. 1985 Jun 15;113(5):411-8.
